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Cyclic nucleotides (cNMPs) regulate the activity
of various proteins by interacting with a
conserved cyclic nucleotide-binding domain
(CNBD). Although X-ray crystallographic stud-
ies have revealed the structures of several
CNBDs, the residues responsible for generating
the high efficacy with which ligand binding
leads to protein activation remain unknown.
Here, we combine molecular dynamics simula-
tions with mutagenesis to identify ligand
contacts important for the regulation of the
hyperpolarization-activated HCN2 channel by
cNMPs. Surprisingly, out of 7 residues that
make strong contacts with ligand, only R632
in the C helix of the CNBD is essential for high
ligand efficacy, due to its selective stabilization
of cNMP binding to the open state of the chan-
nel. Principal component analysis suggests that
a local movement of the C helix upon ligand
binding propagates through the CNBD of one
subunit to the C linker of a neighboring subunit
to apply force to the gate of the channel.
INTRODUCTION
Cyclic nucleotides (cNMPs) regulate the opening of
several classes of ion channels (Craven and Zagotta,
2006) by interacting with a cytoplasmic cyclic nucleotide-
binding domain (CNBD) that has been conserved across
a wide range of proteins, from bacterial transcription fac-
tors to protein kinases (Berman et al., 2005). Surprisingly,
despite recent advances in obtaining X-ray crystal struc-
tures for a number of CNBDs, including those of ion chan-
nels (Clayton et al., 2004; Zagotta et al., 2003), residues
that make essential contributions to ligand efficacy have
not yet been identified. Moreover, the residues that
account for the selectivity of certain CNBDs for cAMP rel-
ative to cGMP also remain elusive. This raises a question
as to whether efficacy and selectivity are distributed
across a number of residues, each interacting weaklyStructure 15, 65with ligand, or whether they depend on strong contacts
with a few specific residues that have not yet been
identified.
The characterization of residues that contribute to
efficacy is of critical importance for understanding how
binding is coupled to channel opening because, accord-
ing to allosteric models, such residues undergo dynamic
interactions with ligand that help selectively stabilize bind-
ing to the open state of the channel (DiFrancesco, 1999;
Monod et al., 1965; Tibbs et al., 1997; Wang et al.,
2002). Thus, the identification of residue contacts that
contribute to cNMP efficacy can be used to map regions
of the CNBD that must move relative to ligand during
channel opening. In contrast, residues that contribute to
binding affinity, but not to efficacy, remain static relative
to ligand during channel activation.
Here, we examine the contributions of specific CNBD
residues to the binding, selectivity, and efficacy with
which cNMPs regulate the gating of the HCN2 hyperpolar-
ization-activated cation channels (Ludwig et al., 1998;
Santoro et al., 1998). The HCN channels provide an ad-
vantageous experimental system due to several factors.
First, these channels are dually gated by membrane
hyperpolarization and cNMP binding, which enhances
opening by shifting the voltage dependence of activation
to more positive potentials (Craven and Zagotta, 2006;
Robinson and Siegelbaum, 2003). Thus, measurements
of the maximal voltage shift at saturating concentrations
of cNMP provide a convenient and direct measure of
ligand efficacy. Moreover, because HCN channels have
a much higher sensitivity to cAMP compared to cGMP,
they are useful for determining mechanisms of ligand
selectivity. Finally, X-ray crystal structures are available
for the cAMP- and cGMP-bound forms of a soluble C-
terminal region of HCN2, consisting of the CNBD and
the C linker domain (Zagotta et al., 2003).
The CNBD of HCN2 shows a highly conserved fold,
consisting of an initial a helix (A helix), followed by an
eight-stranded antiparallel b roll (b1–b8), a short B helix,
and a long C helix. The C linker consists of six a helices
(A0–F0) and connects the CNBD to the C-terminal end of
the S6 transmembrane segment, where the channel gate
is located (Rothberg et al., 2002). Several lines of biophys-
ical studies suggest that the binding of cNMP promotes5–670, June 2007 ª2007 Elsevier Ltd All rights reserved 655
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Cyclic Nucleotide Gating of HCN Channelsthe assembly of four C-terminal regions into a four-fold
symmetric tetrameric gating ring (reflecting the tetrameric
structure of the native channel), whose intersubunit con-
tacts are largely mediated through the C linker (Zagotta
et al., 2003; Zhou et al., 2004). A number of studies sug-
gest that the helical regions of various CNBDs undergo
significant motions during ligand-dependent activation,
whereas the b roll remains relatively static (Clayton et al.,
2004; Gordon et al., 1996; Gullingsrud et al., 2006; Matulef
and Zagotta, 2002; Mazzolini et al., 2002; Tibbs et al.,
1998; Varnum et al., 1995; Vigil et al., 2006; Young and
Krougliak, 2004). In particular, interactions between C
helix residues and bound ligand are thought to contribute
to cNMP efficacy and cGMP selectivity in CNG channels
(Goulding et al., 1994; Varnum et al., 1995), although no
single residues have been identified that are essential for
generating high efficacy.
To search for residues that might contribute to ligand
efficacy and selectivity, we used a combined approach
of molecular dynamics (MD) simulations (Karplus and
McCammon, 2002) with functional mutagenesis to pro-
vide an unbiased scan of the interaction of cAMP and
cGMP with the CNBD of HCN2. We identified several
key residues important for high-affinity ligand binding
and cAMP selectivity. Surprisingly, out of 7 binding site
residues found to interact strongly with ligand, only 1
residue, R632 in the C helix, is critical for achieving high
efficacy. MD simulations indicate that R632 makes strong
electrostatic and van der Waals (VDW) interactions with
bound ligand that stabilize the position of the C helix rela-
tive to the core of theCNBD. Local motions of theC helix in
response to ligand binding propagate throughout the
CNBD to influence the opening of the transmembrane
gate of the channel.
RESULTS
Molecular Dynamics Simulations
Our strategy involves the use of MD simulations to identify
residues that interact strongly with bound ligand, followed
by mutagenesis studies to determine the importance of
such residues for ligand-binding affinity, selectivity, and
efficacy. MD simulations were performed for both the
cAMP- and cGMP-bound states of the homotetrameric
HCN2 C-terminal region (D443–L643) based on the
X-ray crystal structures (Zagotta et al., 2003). The final
system including explicit water is of significant size (close
to 80,000 atoms), limiting the simulation timescale to
40 ns. The root mean square deviations of the protein
backbone and bound cNMPs reach equilibrium after
2–3 ns (Figure 1A), reflecting the typical relaxation of a
crystal structure during an MD simulation (Fan and Mark,
2004). The atomic fluctuations based on MD simulations
are closely correlated with fluctuations from crystallo-
graphic B factors (Zagotta et al., 2003) (Figure 1B), indicat-
ing that the simulations reflect genuine protein dynamics.
One surprising feature of the X-ray structures is that cAMP
is bound in the anti conformation, whereas cGMP is bound
in the syn conformation, reflecting distinct dihedral angles656 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rigbetween the ribose and purine rings. The bound ligands
remain in their original conformation during the 40 ns MD
simulations, although there are significant fluctuations in
the dihedral angle (Figure S1A; see Supplemental Data
available with this article online).
There are no large alterations in the structure of the
protein in the MD trajectories (Figure S1B). However, the
restricted timescale and sampling of the conformational
space in our simulations are not expected to encompass
large-scale structural changes associated with gating,
which require microseconds to milliseconds to reach
completion. Nonetheless, our simulations are able to pro-
vide insight into local, short-range interactions between
ligand and CNBD residues.
Representative snapshots from the MD trajectories
were used to calculate the electrostatic potential gener-
ated by the partial charges on bound ligands (Figure 1C).
The side chains of several surrounding charged or polar
residues fall within (R591, T592) or in close contact with
(E582, R632, R635) the potential isosurface of the cNMP
at the 0.5 kT/e level. A molecular surface representation
shows that these side chains reach out like the fingers of
a hand to grasp the bound ligand in its center (Figure 1D).
Based on an ensemble of 5000 frames from a 5–10 ns
MD trajectory, we calculated the mean electrostatic
(Coulombic) and VDW potential energies of interaction
(Figures 2A–2C), as well as the mean number of H bonds
(Figure 2D) between each residue in the CNBD and the
bound cNMP. This method provides an index of the rela-
tive contributions of different residues to the strength of
ligand binding, including residues not fully resolved in
the X-ray structure (see Experimental Procedures for
a partial list). We identified 7 residues that make especially
strong interactions with ligand: R591, T592, and E582 of
the b roll, and R632, R635, I636, and K638 of the C helix.
As discussed below, mutations of R591, T592, and I636
were previously shown to alter the gating of HCN and
CNG channels by cNMPs (Craven and Zagotta, 2006),
supporting the validity of our analysis. In contrast, the
function of the remaining residues (E582, R632, R635,
and K638) has not yet been examined for either CNG or
HCN channels. Furthermore, R635 and K638 are either
missing or only partly resolved in the X-ray structures.
Below, we examine the roles of these 7 residues in the
cNMP-dependent activation of HCN2 in more detail by
characterizing the effects of their point mutation on the
MD trajectories and channel function.
Importance of b Roll Residues R591 and T592
in cNMP Regulation
We first examined the interactions of R591, which is the
most highly conserved residue of the CNBD and is impor-
tant for high-affinity binding in a variety of CNBD-contain-
ing proteins, including CNG (Tibbs et al., 1998) and HCN
(Chen et al., 2001) channels. R591 is completely buried
in the 0.5 kT/e electrostatic potential contour generated
by ligand and exerts the strongest electrostatic interaction
with the cNMP due to the formation of an ionic bond
with the cyclized phosphate (Figure 1C). Our simulationshts reserved
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Cyclic Nucleotide Gating of HCN ChannelsFigure 1. Molecular Dynamics Simulation of the cNMP-Bound HCN2 CNBD
(A) Root-mean-square deviation (rmsd) of the protein backbone (left) and atoms in the bound cNMP (right). Black, cAMP; red, cGMP.
(B) Comparison of the root mean square fluctuation (rmsf, solid line) with atomic displacements from B factors (dash line) of the crystal structures. For
comparison purposes, rmsf values averaged for the four subunits of a homotetramer are plotted against the residue number in the primary protein
sequence of a subunit.
(C) Snapshots from 5–10 nsMD trajectories based on backbone rmsd analysis. The relative positions of cAMP (left) or cGMP (right) and key interacting
residues are shown. The colored isosurface shows the cNMP electrostatic potential at the 0.5 kT/e level (red, negative; blue, positive).
(D) Molecular surface representation for the structures shown in (C). Default van der Waals radii for each atom are shown. Water molecules within 7 A˚
of the bound ligands are also shown.Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rights reserved 657
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Cyclic Nucleotide Gating of HCN ChannelsFigure 2. Nonbonded Potential Energy
and the H Bond Formed between the
Ligand and Each Residue in the Binding
Domain
Top, secondary structure of the CNBD; the
residue position number is indicated below.
(A–C) Ensemble averaged potential energies
between a single subunit and the bound
cNMP. (A) Electrostatic (Coulomb) potential
energies plotted as a function of residue posi-
tion. ECoul is the sum of short-range and long-
range Coulomb energies (see Experimental
Procedures). (B) Van derWaals (VDW) potential
energies. EVDW is the sum of short-range and
the long-range Lennard-Jones energies (see
Experimental Procedures). (C) Sum of non-
bonded potential energies (ECoul + EVDW).
(D) Mean number of H bonds between a given
residue and bound ligand expressed as
summed probabilities of each potential H
bond.support the presence of a strong salt bridge between
R591 and the cNMP, since the distance between the CZ
atom of R591 and the phosphorous atom of cGMP (5 A˚)
is very stable during the MD trajectory (data not shown).
Next, we examined the effects of R591 mutations on
HCN2 ligand gating. Previous studies demonstrate
a nearly complete loss of cNMP response in R591E mu-
tant channels, which precludes an analysis of whether
this residue is required for efficacy or binding (Chen
et al., 2001). We, therefore, examined a less disruptive
mutation, R591A. Wild-type HCN2 channels open in
response to hyperpolarization with a voltage-dependent
activation curve that is well described by a Boltzmann
relation, characterized by the voltage at which channels
are half activated, the V1/2 (Figure S2). As previously
described (e.g., Craven and Zagotta, 2006), cAMP and
cGMP shift the voltage dependence of activation to
more positive potentials and increase the maximal current
amplitude (IN) during steps to negative voltages, where
voltage-dependent activation is complete (Figures S2A
and S2B), an effect that reflects an increase in themaximal
open probability of the channel (Chen et al., 2007). The
effects of the cNMP were characterized by plotting dose-
response curves for the shift in V1/2 (DV1/2) as a function of
ligand concentration. Themaximal voltage shift at saturat-
ing [cNMP], DVmax, provides a direct measure of ligand658 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rigefficacy, whereas the concentration of ligand that pro-
duces a half-maximal voltage shift, K1/2(V), provides a
measure of the sensitivity of the channel to the cNMP
(Figure S2C). The dose-response curves reveal that
HCN2 is 60-fold more sensitive to cAMP than to cGMP
(K1/2(V) = 0.1 mM for cAMP versus 6.4 mM for cGMP; Table
1), although the efficacy of the two agonists is nearly iden-
tical (DVmax equals +18.3 mV for cAMP versus +17.4 mV
for cGMP).
The R591A mutant shows normal hyperpolarization-
activated gating in the absence of the cNMP, with a V1/2
value identical to that of wild-type HCN2 (Table 1). More-
over, cNMP binding enhances the opening of R591A in
a manner qualitatively similar to that of wild-type HCN2
(Figures 3A and 3B). However, themutant shows amarked
reduction in sensitivity to both cAMP and cGMP
(Figure 3B), with a 28-fold and 23-fold increase in K1/2(V)
for cAMP and cGMP, respectively (Figure 3B; Table 1).
Notably, although R591 is required for high-affinity bind-
ing, it does not contribute to efficacy, since R591A shows
a normal-sized DVmax in response to either cAMP or
cGMP (Figure 3B; Table 1), similar to results in CNG chan-
nels (Tibbs et al., 1998).
We next investigated the contribution of the neighboring
residue, T592, since the equivalent threonine in the
CNBDs of both PKG (Shabb et al., 1991) and CNGhts reserved
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Cyclic Nucleotide Gating of HCN ChannelsTable 1. Summary of Experimental Results for Wild-Type and Mutant Channels
cAMP cGMP
V1/2 (mV) DVmax (mV) K1/2(V) (mM) DVmax (mV) K1/2(V) (mM)
Wild-type 129.8 ± 0.7 18.3 ± 0.3 0.10 ± 0.01 17.4 ± 0.5 6.40 ± 0.80
E582A 132.3 ± 0.7 15.4 ± 0.5 47.3 ± 8.4 10.8 ± 6.4 1269 ± 2219
R591A 133.3 ± 1.1 19.2 ± 0.5 2.8 ± 0.3 17.0 ± 0.4 150 ± 15
T592A 131.8 ± 2.4 17.6 ± 0.7 0.74 ± 0.16 12.7 ± 0.6 111.7 ± 17.1
I630A 130.2 ± 2.0 16.2 ± 0.3 0.21 ± 0.02 16.2 ± 1.0 7.8 ± 2.9
D631A 133.8 ± 1.0 18.5 ± 2.1 1.4 ± 0.5 17.3 ± 0.7 5.9 ± 1.5
R632A 130.8 ± 1.0 0.2 ± 0.6 24.0 ± 4.9a 2 ± 0.5 16.3 ± 0.7a
L633A 132.2 ± 0.9 14.0 ± 0.6 14.8 ± 3.3 8.1 ± 0.6 16.2 ± 8.0
D634A 129.7 ± 1.2 16.6 ± 0.4 0.10 ± 0.01 14.7 ± 1.1 7.9 ± 3.2
R635A 131.2 ± 1.1 20.2 ± 0.9 0.65 ± 0.12 15.4 ± 0.3 7.9 ± 0.7
R635D 130.9 ± 0.9 19.6 ± 0.4 2.85 ± 0.27 16.2 ± 0.9 13.0 ± 2.7
I636A 131.7 ± 1.6 19.6 ± 1.0 1.7 ± 0.4 20.2 ± 0.7 3.8 ± 0.6
I636D 133.2 ± 1.1 18.5 ± 0.7 16.1 ± 3.4 22.9 ± 0.4 0.96 ± 0.09
K638A 131.1 ± 1.3 19.2 ± 1.08 0.8 ± 0.3 16.7 ± 0.3 7.1 ± 0.6
K638D 131.8 ± 1.2 20.3 ± 0.7 2.0 ± 0.4 18.0 ± 0.5 4.5 ± 0.8
V1/2 is the mid-point voltage of activation in the absence of the cNMP. DVmax is the maximal shift in the tail current activation curve
with saturating [cNMP]. K1/2(V) is the cNMP concentration producing the half-maximal voltage shift.
a The value is based on the K1/2 for the increase in macroscopic current (K1/2(I)).channels (Altenhofen et al., 1991; Shabb et al., 1991) con-
tributes to cGMP selectivity. Consistent with the previous
findings, our MD simulations show that T592 forms one
more H bond with cGMP (three H bonds) compared to
cAMP (two H bonds) (Figures 3C and 3E). Our experimen-
tal data support these results, since T592A mutant chan-
nels show a more pronounced loss of sensitivity to
cGMP than to cAMP. However, the efficacy of cGMP is
only slightly decreased (25%) and remains unchanged
for cAMP (Figure 3D; Table 1).
R635, I636, and K638: C Helix Residues Important
for cAMP Selectivity
Since HCN channels are normally 60-fold selective for
cAMP over cGMP, whereas T592 selectively stabilizes
the binding of cGMP, other residues in the CNBD must
provide an even greater energetic contribution to prefer-
entially stabilize cAMP. We first focused on I636 in the C
helix, since, in CNGA1, the substitution of a large neutral
residue for an aspartate normally found at the correspond-
ing position (D604) converts the cGMP-selective CNGA1
channel into one that prefers cAMP (Varnum et al.,
1995). Consistent with these results, we find that I636A
mutant HCN2 channels show a marked loss of their ability
to select for cAMP versus cGMP, due to both a 15-fold
loss of sensitivity to cAMP and a 2-fold enhancement of
sensitivity to cGMP (Figure 4A; Table 1). In contrast, I636
does not contribute to efficacy, since the I636A mutant
channels display no change in DVmax for either cAMP or
cGMP (Table 1). In further agreement with results inStructure 15, 65CNGA1, the I636D substitution converts HCN2 into
a cGMP-selective channel (Figure 4A). Thus, I636D shows
both a 160-fold increase in its K1/2(V) for cAMP and a 6.5-
fold decrease in its K1/2(V) for cGMP (relative to wild-type
HCN2). In addition, the DVmax of cGMP is enhanced by
30%; there is no change for cAMP (Table 1).
It was previously suggested that cGMP selectivity in
CNGA1 is due to the formation of a pair of H bonds
between the guanine ring of cGMP and the aspartyl
carboxylate oxygens (Varnum et al., 1995). However, our
MD simulations indicate that the H bonds are unstable
(Figure 4B). Rather, the aspartate appears to form a stabi-
lizing electrostatic interaction with the partial positive
charges on the hydrogen atoms on the guanine N2 and
N1 atoms of cGMP and a repulsive interaction with the
partial negative charge on the adenine N7 atom of cAMP
(Figure 4C).
Since I636A retains some selectivity for cAMP, other
CNBD residues apart from I636 must also help to prefer-
entially stabilize cAMP binding. We next examined R635
and K638, two C helix residues that are highly conserved
among HCN and CNG subunits (Figure 5A) and make
weak electrostatic interactions with the cNMP (Figure 2A).
MD simulations show that the positively charged amine
of R635 interacts with N1 of cAMP or O6 of cGMP
(Figure 1C). R635 and K638 were not fully resolved in the
HCN2 crystal structures, and their functional role has not
yet been examined for any cNMP-regulated channel.
Using alanine substitutions, we find that R635 and K638
make modest, but significant, contributions to cNMP5–670, June 2007 ª2007 Elsevier Ltd All rights reserved 659
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Cyclic Nucleotide Gating of HCN ChannelsFigure 3. Characterization of the Interactions between b Roll Residues R591 and T592 and the cNMP
(A) HCN2 currents in response to a series of hyperpolarizing voltage steps from 90 mV (0 cNMP) or 80 mV (cNMP) in 10 mV increments. Repre-
sentative voltages are indicated. Top row, wild-type HCN2 currents in the presence of 10 mM cAMP (left), in the absence of the cNMP (0 cNMP,
center), or in the presence of 2.5 mM cGMP (right). Bottom row, currents for the R591A mutant at indicated cNMP concentrations.
(B) Dose-response curves for the shift in V1/2 as a function of [cAMP] (left) and [cGMP] (right). Solid lines show the best fits of the Hill equation. Black,
wild-type HCN2; red, R591A mutant. Values of fit parameters are given in Table 1. Error bars indicate SEM.
(C) Number of H bonds between T592 and bound ligand (cAMP, top; cGMP, bottom). Gray traces show the number of bonds every 1 ps, and red
traces show the average within a 50 ps window.
(D) Dose-response curves for DV1/2 as a function of [cAMP] (top) or [cGMP] (bottom) for wild-type HCN2 (black) or the T592A mutant (red). Error bars
indicate SEM.660 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rights reserved
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Cyclic Nucleotide Gating of HCN ChannelsFigure 4. Role of I636 in cNMPSelectivity
(A) Effect of I636 mutations on DV1/2 dose-
response curves for cAMP (left) and cGMP
(right). Solid line, fits of the Hill equation (see
Table 1 for values). Black, wild-type HCN2;
red, I636A; green, I636D. Error bars indicate
SEM.
(B) Number of H bonds between I636D and
cGMP. Data are plotted as in Figure 3C. Left,
H bonds between N1 of the purine ring of
cGMP and I636D; right, H bonds between N2
of cGMP and I636D (see Figure S1B for atom
nomenclature).
(C) Representative snapshots showing the
location of I636D relative to the electrostatic
potential generated by cAMP (left) or cGMP
(right) at the 0.5 kT/e level. The distance
between CG of I636D and N7 of cAMP is 5.3 A˚.
The distance between CG of I636D and C2 of
cGMP (between N1 and N2) is 4.9 A˚.binding and cAMP selectivity. R635A and K638A channels
exhibit comparable decreases in sensitivity to cAMP (6.5-
fold and 8-fold increases in K1/2(V), respectively) while
showing little change in sensitivity to cGMP (Figures 5B
and 5C; Table 1). R635D and K638D mutants display
a larger, 20- to 30-fold increase in K1/2(V) for cAMP, indi-
cating the importance of electrostatic effects, with only
a minor change in cGMP sensitivity (Table 1). Thus, three
C helix residues, R635, I636, and K638, all contribute
binding energy that selectively stabilizes cAMP relative
to cGMP. However, none of these residues contribute to
efficacy, as indicated by the lack of effect of the mutations
on DVmax (Figures 5B and 5C; Table 1).
Residues Important for Coupling Ligand Binding
to Gating
The above-described results do not reveal any CNBD
residues essential for high ligand efficacy. We therefore
examined the 2 remaining residues found by MD simula-
tions to interact strongly with ligand, R632 in the C helixStructure 15, 6and E582 in the b roll. R632 provides the strongest VDW
potential energy of interaction with ligand and the second
strongest electrostatic interaction (after R591, Figure 2).
The X-ray structures of HCN2 (Zagotta et al., 2003) and
the MlotiK1 bacterial K+ channel CNBD (Clayton et al.,
2004) reveal that E582 and R632 (or their corresponding
residues) form a salt bridge (Figure 6A). Our MD simula-
tions also indicate that E582 exerts a repulsive electro-
static interaction with the negative charge of the cNMP,
whereas it forms a stabilizing H bond with the ribose
hydroxyl of ligand (Figure 2D). Interestingly, replacement
in MlotiK1 of the residue corresponding to R632 in HCN2
by alanine leads to a complete loss of channel function
(Clayton et al., 2004; Vigil et al., 2006), although it is not
knownwhether this represents a loss of binding or efficacy.
Our MD simulations suggest that the E582-R632 interac-
tion is quite strong, as judgedby the stability of the distance
between the E582 and R632 side chains (Figure S3A).
Moreover, the E582-R632 ionic bond appears to be criti-
cal for this stability, as large fluctuations in local structure(E) Representative snapshots showing interactions of R591 and T592 with cAMP (top) and cGMP (bottom). T592 makes two H bonds (dashed lines)
with cAMP versus three H bonds with cGMP.55–670, June 2007 ª2007 Elsevier Ltd All rights reserved 661
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Cyclic Nucleotide Gating of HCN ChannelsFigure 5. Function of R635 and K638 in
cNMP-Dependent Regulation of HCN2
(A) Sequence alignment of the C helix from
HCN channels (mouse HCN2 and HCN3, sea
urchin spHCN, bovine CNGA1, rat CNGA2,
rat CNGA4, bacterial MltiK1, and RpalK1 chan-
nels [Clayton et al., 2004] and the bacterial
transcription factor, CAP). R635 and K638 of
HCN2 are indicated by black boxes.
(B) DV1/2 dose-response curves for cAMP (left)
or cGMP (right) in HCN2 (black), R635A (red),
or R635D (green). The data for wild-type
HCN2 is the same as that shown in Figure 4.
Error bars indicate SEM.
(C) Comparison ofDV1/2 dose-response curves
for cAMP (left) or cGMP (right) for HCN2
(black), K638A (red), or K638D (green). Param-
eter values are given in Table 1. Error bars
indicate SEM.are seen during simulations of an E582A mutant (Figures
S3B and S3C).
As the functional role of E582 has not yet been reported
for any cNMP-regulated channel, we characterized the
properties of the E582A mutant. These channels activate
normally in response to hyperpolarization and respond
to cGMP or cAMP in a manner qualitatively similar to
wild-type HCN2. However, the sensitivity of E582A
channels to ligand is drastically reduced. The K1/2(V) is in-
creased 430-fold for cAMP and could not be determined
for cGMP since its dose-response curve fails to saturate,
even at millimolar concentrations of ligand (Figure 6B).
Thus, the E582-R632 salt bridge appears to make an
important, stabilizing contribution to cNMP binding that
outweighs any repulsive electrostatic interaction between
E582 and ligand (Figure 2A). Importantly, the mutation
causes only a modest decrease in DVmax (16%) with
cAMP, indicating that E582 is not required for high
efficacy.
We next considered the role of R632, which, as dis-
cussed above, makes very strong ionic and VDWcontacts
with ligand (Figure 2). Consistent with the theoretical
results, the R632A mutant has the most dramatic pheno-
type of any alanine substitution. Thus, the ability of
cAMP to shift voltage gating to more positive potentials662 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All righis abolished by themutation, even at millimolar concentra-
tions of ligand (Figures 6C and 6D; Table 1). The voltage
shift with cGMP is also largely eliminated, although a small
shift (+2 mV) remains with 2.5 mM cGMP.
A key question is whether the lack of voltage shift repre-
sents a loss of efficacy or binding. Evidence that R632A
channels can still bind ligand comes from our finding
that the mutant channels display a near normal-sized
(50%–80%) increase in IN in response to cAMP and
cGMP (Figures 6C and 6E; Table 2; Table S1). For wild-
type HCN2, the cAMP and cGMP concentrations produc-
ing a half-maximal increase in IN, K1/2(I), are equal to
0.04 mM and 0.8 mM, respectively. For R632A, the K1/2(I)
values for cAMP and cGMP are increased to 24 mM and
16 mM (Figure 6E; Table 1), respectively. Although these
results show that the R632A mutation dramatically
reduces the sensitivity of the channel to ligand, they also
indicate that the channel can still bind cAMP, and at
cNMP concentrations at least 40-fold lower than those
that fail to elicit a shift in voltage gating (based on the rela-
tive difference between the K1/2(I) value for cAMP versus
the lack of voltage shift in response to 1 mM cAMP). Thus,
the loss of the ability of cAMP to shift voltage gating in
R632A channels reflects a profound decrease in efficacy,
rather than a simple loss of binding affinity.ts reserved
Structure
Cyclic Nucleotide Gating of HCN ChannelsFigure 6. Function of E582 and R632 in
cNMP-Dependent Regulation of HCN2
(A) Representative snapshots from MD simula-
tions showing the positions of E582 and R632
in cAMP-bound (left) and cGMP-bound (right)
CNBDs.
(B) Comparison ofDV1/2 dose-response curves
for cAMP (left) and cGMP (right) for wild-type
HCN2 (black, from Figure 3) and E582A mutant
(red) channels. Error bars indicate SEM.
(C) R632A currents in absence (left) or pres-
ence (right) of 1mMcAMPduring hyperpolariz-
ing steps to different voltages in 10 mV incre-
ments (representative voltages are indicated).
(D) Normalized tail current activation curves for
R632A channels in the absence (black) or pres-
ence of 1 mM cAMP (red). The activation curve
for wild-type HCN2 in the presence of 10 mM
cAMP (green) is shown for comparison. Wild-
type activation curve in absence of ligand
was similar to that of R632A (black line). Solid
lines show fits of the Boltzmann equation
(values are given in Table 1).
(E) Dose-response curves for increase in max-
imal tail current amplitude of R632A channels.
Maximal tail current amplitude in the presence
of the cNMP (IN[cNMP]) normalized by maxi-
mal tail current in the absence of ligand (IN[0]).
Curves are fit by the Hill equation (parameters
in Table S1). Error bars indicate SEM.
(F) Effect of cAMP on the R632A and R632A/
R591E channel current. Left, effect of different
concentrations of cAMP on currents elicited
by a test pulse to 140 mV for R632A. Right,
currents for the R632A/R591E double point
mutant.Why do R632A channels still show a significant increase
in maximal current with the cNMP whereas the voltage
shift is abolished? Might the enhancement in maximal
current and the shift in voltage gating reflect two distinct
actions of ligand at two separate binding sites? Prece-
dence for dual effects is seen in the bacterial cAMP-bind-
ing protein, CAP, in which cAMP binds to a high-affinity
site within the CNBD and to a second, low-affinity site out-
side the CNBD (Passner and Steitz, 1997). However, both
experimental and theoretical results suggest that the
effects of the cNMP inwild-type andmutantHCN2channels
on IN and DVmax represent a single action at the canonical
CNBD-binding site.
Experimental support for a single binding site comes
from an examination of channels containing both the
R632A and R591E mutations. As described previously,Structure 15, 6the R591E mutation eliminates a key electrostatic interac-
tion of the cNMP with the conserved core of the CNBD,
leading to a loss of the ability of ligand binding to produce
a shift in voltage gating (Chen et al., 2001). We now find
that, in the background of the R632A mutation, the R591E
mutation also eliminates the ability of the cNMP to increase
IN (Figure 6F). This strongly argues that the effects of ligand
binding to increase IN and shift voltage gating represent
a single action at the canonical cNMP-binding site within
the core of the CNBD (Figure 6F). Theoretical support for
a single site of action is presented below.
Another potential concern in interpreting the R632A
data is whether the loss of efficacy is due to an effect of
the mutation to disrupt the global CNBD structure. How-
ever, four lines of experimental evidence argue for a spe-
cific, local effect of the mutation. First, the voltage gating55–670, June 2007 ª2007 Elsevier Ltd All rights reserved 663
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Cyclic Nucleotide Gating of HCN ChannelsTable 2. Values for Dissociation Constants for cNMP Binding to the Closed, KC, or Open, KO, States of Wild-Type
and Mutant Channels Obtained from the Six-State Model
cAMP cGMP
Pmax[sat]Pmax[0] KO (mM) KC (mM) Pmax[sat]Pmax[0] KO (mM) KC (mM)
Wild-type 1.425 0.008 0.844 1.287 0.611 52.1
E582A 1.473 6 253.2 1.634 195.9 5032
R591A 1.681 0.188 24.8 1.429 11.7 1341
T592A 1.297 0.079 5.346 1.443 22.9 378
I630A 1.43 0.02 2.4 1.43 0.66 56.7
D631A 1.43 0.06 9.8 1.43 0.44 79.2
R632A 1.473 21.8a 36.6a 1.49 14.7a 37.2a
D634A 1.43 0.02 2.55 1.43 1.0 51.4
R635A 1.792 0.033 7.038 1.764 0.889 39.8
R635D 1.835 0.152 29.1 2.088 1.132 71.5
I636A 1.517 0.121 15.8 1.513 0.248 38.5
I636D 1.634 1.192 133 1.669 0.052 10.5
K638A 1.312 0.06 8.13 1.590 0.609 52.1
K638D 1.497 0.083 32.3 1.689 0.246 48.7
Values of Pmax[sat]/Pmax[0] are given by experimental values for Imax[sat]/Imax[0].
a The value is based on (K1/2(I)), by using Equations 13A and 18A. All other values are based on K1/2(V) and Equations 16A and 17A.of R632A channels is normal in the absence of the cNMP,
with no change in V1/2 (Table 1), a parameter that is sensi-
tive to changes in CNBD structure (Chen et al., 2001;
Wainger et al., 2001). Second, as seen above, efficacy
remains unchanged with alanine substitutions in 3 nearby
residues: R635A, I636A, and K638A. Third, we examined
four additional alanine-substituted mutations in the near-
est neighbors of R632 and find either no effect on cNMP
efficacy (I630A, D631A, and D634A; see Table 1) or only
a modest decrease (L633A, < 25% reduction in DVmax;
Table 1). Thus, out of 8 C helix residues examined, only
R632 is essential for the generation of high ligand efficacy.
Fourth, the finding that the increase in IN in response to
micromolar concentrations of the cNMP is preserved in
the R632A mutant indicates that the mutant CNBD is still
capable of relatively high-affinity interactions with ligand.
A Cyclic Allosteric Model Explains the Effects of the
cNMP to Shift Voltage Gating and Increase IN in
Wild-Type and Mutant Channels
We used a cyclic allosteric model both to demonstrate
how the differential effects of the R632A mutation on IN
and DVmax can be explained by a single alteration at a sin-
gle binding site and to determine dissociation constants
for cNMP binding to the closed (KC) and open (KO) states
of wild-type and mutant channels. According to the model
(Chen et al., 2007) (Supplemental Data and Figure S4A),
agonist efficacy is due to the tight coupling of the confor-
mational change that opens the channel with a conforma-
tional change in the CNBD that increases the affinity of the
open state of the channel for ligand (that is, KO < KC). In the
absence of the cNMP, HCN channels undergo a voltage-664 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rigdependent transition from a closed resting state (CR) to
a closed activated state (CA) upon hyperpolarization, fol-
lowed by a voltage-independent transition to the open
activated state (OA): CR$KV CA$L OA, where KV is the
voltage-dependent equilibrium for activation, and L is
the voltage-independent opening equilibrium (L= CAOA). Be-
cause ligand binding and opening are linked in a cyclic
scheme (Figure S4A), the tighter binding of the cNMP to
the open state enhances the opening equilibrium for the li-
ganded channel relative to the opening equilibrium of the
unliganded channel by a factor equal to KCKO. Importantly,
as shown in Figure S4A, the model shows that mutations
that decrease the KCKO ratio can produce a large decrease
in cNMP efficacy, as measured by DVmax, with much
less effect on the ability of cNMP binding to enhance IN
(due to a differential sensitivity of the two parameters to
KC
KO
), similar to our findings with R632A.
As outlined in Experimental Procedures and discussed
in detail in Supplemental Data, the model permits us to
solve for KC and KO based on measurements of DVmax,
K1/2(V), and the fractional increase in IN with saturating
[cNMP]. These calculations indicate that cAMP binds to
wild-type HCN2 with KO and KC values equal to 8 nM
and 844 nM, respectively, yielding a KC/KO ratio of
100. For cGMP, the values for KO and KC are equal to
0.6 mM and 52 mM, respectively, yielding a KC/KO ratio of
85, slightly lower than that achieved with cAMP. Nearly
all mutations alter KC and KO by equal factors; thus, the
KC/KO ratio, and, as a result, ligand efficacy, is relatively
unchanged (Table 2; Figure S4C). In contrast, the R632A
mutation produces a relatively selective loss of binding
affinity for the open state: there is a 1700-fold increasehts reserved
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Cyclic Nucleotide Gating of HCN ChannelsFigure 7. MD Simulations of the R632A
Mutant CNBD andWild-Type Unliganded
CNBD
(A) Distance between C-a atoms of E582 and
R632 (wild-type, left) or R632A (R632A mutant,
right) plotted as a function of simulation time,
for one representative subunit. Red traces,
running average with 50 ps window.
(B) Averaged distances (50 ps window) be-
tween the mass center of bound cAMP and
the mass center of C-a atoms of D631, R632,
and L633. Left, wild-type CNBD; right, R632A
mutant. The different colors represent each of
four subunits.
(C) Left, representative snapshots showing the
structure of the cAMP-bound (green) and
unbound (red) states of the wild-type CNBD.
Right, distance distributions between C-a
atoms of E582 and R632 during the 5–20 ns
of MD trajectories for the wild-type CNBD
either with cAMP bound (green) or without
ligand (red). Bin size, 0.05 A˚.
(D) Averaged distances (50 ps window)
between the C-a atoms of E582 and R632
from four subunits shown in different colors.
Left, wild-type CNBD with cAMP bound; right,
wild-type CNBD in the absence of cAMP.in KO (16.3 mM, Table 2), compared to a more modest 30-
fold increase in KC (25 mM). As a result, the ratio of KC/KO in
R632A is reduced to 1.5, reflecting a nearly 70-fold loss of
efficacy (Table 2; Figure S4C). The R632A mutation also
alters ligand selectivity so that KC and KO for cGMP are
nearly identical to their respective values for cAMP (Table
2). Thus, R632 is important for generating ligand selectivity
in addition to efficacy.
Structural Changes Introduced by the R632A
Mutation
The above-described results indicate that R632 is unique
among the 11 CNBD residues we examined in providing
a critical determinant of efficacy. To gain insight intoStructure 15, 6how R632 contributes to channel function, we performed
MD simulations to examine the structural changes associ-
ated with the R632A mutation (Figure 7). Although we find
no significant alterations in the overall backbone or qua-
ternary structure of the CNBD or C linker within the time
limits of the simulations, the mutation does lead to pro-
nounced local movements in the CNBD. Whereas the
distance between the C-a atoms of E582 and R632 is
normally very stable, it fluctuates markedly in the mutant,
although the average distance is unchanged (Figure 7A).
Furthermore, the distance between the bound cNMP
and the center of the C-a atoms of C helix residues
D631, R632, and L633, which is normally stable in wild-
type HCN2, also varies in the mutant (Figure 7B).55–670, June 2007 ª2007 Elsevier Ltd All rights reserved 665
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Cyclic Nucleotide Gating of HCN ChannelsFigure 8. Principal Component Analysis
of a Combined MD Trajectory of
Unliganded and cAMP-Bound Protein
(A) Projection of the MD trajectories on the first
(left) and second (right) eigenvectors of the
covariance matrix of C-a atoms. Black, projec-
tions of the first 40 ns of the combined trajec-
tory (unliganded state); red, projections of the
40–80 ns portion of the combined trajectory
(cAMP-bound state).
(B) Left, crossplot of the projections on eigen-
vector 1 (x axis) and eigenvector 2 (y axis) for
each time point in the trajectories. Right,
projections on eigenvector 3 (x axis) and eigen-
vector 4 (y axis). Black, unliganded state
protein; red, cAMP-bound protein.
(C) Left, four regions in the CNBD and C linker
identified by the correlated motions repre-
sented by the most significant (first) eigen-
vector (see text). Regions I (ice blue), II (cyan),
and III (orange) are from the same subunit,
and region IV (yellow) is from a neighboring
subunit. Color-matched labels (I–IV) are shown
in the figure. Right, porcupine plot showing
the direction and amplitude of conformational
changes between unliganded and cAMP-
bound states represented by the first eigen-
vector for two neighboring subunits. Movies
showing the corresponding motions are
provided in Supplemental Data.Our finding that R632 selectively stabilizes the binding
of ligand to the open state of the channel indicates that
this residue must move relative to ligand during channel
opening. To gain insight into the earliest stages of such
motions, we simulated the structure of the unliganded
wild-type CNBD. Without the cNMP, the distance be-
tween the C-a atoms of R632 and E582 collapses, on
average, by 1 A˚, with a pronounced broadening of the
distribution, indicating increased motion (Figures 7C and
7D). Thus, MD analyses of both the liganded R632A
CNBD and the unliganded wild-type CNBD suggest that
perturbations that favor the closed state of the channel
destabilize the C helix relative to the core of the CNBD.
Long-Range Correlated Protein Motions Revealed
by PCA Analysis
To address how C helix movements may alter movements
of the channel gate, we applied a principal component
analysis (PCA) to the MD trajectories to identify the essen-
tial correlated motions throughout the CNBD and C linker
(Amadei et al., 1993; Garcia, 1992; Ichiye and Karplus,
1991). This method provides a means of identifying large,
concerted conformational rearrangements that may be666 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All rigrelevant to protein function, and separating such motions
from local, random fluctuations. Themajor components of
the correlated motions were determined by diagonaliza-
tion of the covariance matrix for the C-a atoms of the
protein, obtained from 40 ns MD trajectories of the unli-
ganded and cAMP-bound protein. The resulting eigen-
values of the covariance matrix yield the mean square
displacements (MSD) associated with each component, or
eigenvector, of correlated motion. The eigenvectors rep-
resent the different directions of the correlated motions,
and they are ranked in descending order according to the
values of their associated eigenvalues. Thus, eigenvector
1 has the largest eigenvalue and provides the best fit to
the most significant correlated motions of the protein.
To determine the relevance of the motions represented
by this analysis for ligand gating, we projected the MD
trajectories for the liganded and unliganded HCN2 CNBD
and C linker along the first few (the most relevant) eigen-
vectors, providing a measure of the overall motion along
the directions indicated by the eigenvectors as a function
of time during the simulation (Figure 8).We observe a clear
separation between the motions of the unliganded and
cAMP-bound protein along eigenvector 1 (Figure 8A).hts reserved
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Cyclic Nucleotide Gating of HCN ChannelsThis suggests that the correlated motions represented
by eigenvector 1 may reflect important conformational
changes associated with ligand gating. In contrast, pro-
jections of eigenvectors 2–8 do not reveal a dependence
on ligand occupancy, suggesting that these components
of motion may not be relevant for ligand gating (Figures
8A and 8B; Figure S5). We therefore used eigenvector 1
to filter the MD trajectories and isolate the intrasubunit
and intersubunit motions associated with this component
(Figure 8C).
Based on the above-described procedure, the C termi-
nus of HCN2 can be divided into four domains thatmove in
distinct directions and with different amplitudes: region I,
consisting of the inner part of the CNBD (b2–b8); region
II, consisting of the B and C helices of the CNBD; region
III, consisting of the last four a helixes (C0–F0) of the C
linker; and region IV, consisting of the first two a helixes
(A0 and B0) of the C linker from a neighboring subunit (Fig-
ure 8C, left). cAMP binding to the core-binding pocket (I)
appears to push the C-terminal ends of the C and B
helices (II), which behave like a release lever, moving
region III along the center (four-fold symmetry) axis of
the molecule. In turn, the up-down movement of region
III triggers a rotation-translation movement of the A0 helix
in region IV of the neighboring subunit (Figure 8C, right).
(See Supplemental Data for two movies based on the first
eigenvector.)
DISCUSSION
Here, we have used MD simulations to guide and interpret
mutagenesis studies of the HCN2 CNBD. Our results
provide new insights into the contributions of previously
studied CNBD residues to ligand binding and gating. In
addition, we identify several functional interactions be-
tween bound cNMPand the CNBD that, to our knowledge,
were previously unknown. Importantly, we identify a resi-
due, R632 of the C helix, that is specifically required for
the generation of cNMP efficacy, a role not previously
reported. R632 coordinates a triad of contacts between
ligand, the C helix, and the core of the CNBD that enhance
channel opening by selectively stabilizing ligand binding
to the open state of the channel.
In addition to R632, we characterized a number of
CNBD residues identified by the MD simulations as mak-
ing strong contacts with ligand. Many of the strongest in-
teractions we observe are mediated by residue contacts
with the phosphate or ribose moieties of ligand, the invari-
able regions between cAMP and cGMP. This may explain
why HCN channels show efficient activation by a range of
cNMPs (Bois et al., 1997). However, HCN channels do
show a high degree of selectivity for cAMP relative to
cGMP. In contrast, certain CNG channels are selective
for cGMP. How do the different CNBDs select for cGMP
or cAMP?
Previous studies of the CNGA1 channel determined that
its cGMP selectivity depends on a threonine residue in the
b roll (Altenhofen et al., 1991) and an aspartate residue in
the C helix (Varnum et al., 1995), corresponding to T592Structure 15, 6and I636, respectively, in HCN2. Our findings on HCN2
are in general agreement with these previous studies.
Thus, T592 in HCN2 helps stabilize cGMP binding by
forming an additional H bond with the guanine ring of
cGMP compared to its interaction with the adenine ring
of cAMP. Importantly, replacement of I636 with the
aspartate present in CNGA1 converts HCN2 into a cGMP-
selective channel. MD simulations indicate that the aspar-
tate forms a favorable electrostatic interaction with the
partial positive charge on the guanine ring and a repulsive
electrostatic interaction with the partial negative charge
on the adenine ring. The agreement between results in
CNG and HCN channels indicate that the two CNBDs
adopt a very similar overall structure.
In contrast to these well-defined interactions that stabi-
lize cGMP binding, the mechanisms of cAMP selectivity
remain uncertain. We find that cAMP selectivity is distrib-
uted across a number of C helix residues, including R632,
R635, I636, and K638. However, it is not immediately ap-
parent how such residues generate selectivity. Preliminary
calculations with several MD simulation-based methods,
such as the linear interaction energy method with explicit
solvent treatment (Aqvist et al., 1994) or continuum elec-
trostatic approaches, reveal that the solvation energy of
cGMP is 10 kcal/mol more favorable than that of
cAMP. This reflects both differences in chemical structure
between the adenenine and guanine groups as well as
differences in stereochemical conformations (anti for
cAMP versus syn for cGMP). Thus, cAMP selectivity
may at least partially arise because the binding of cGMP
to the CNBD is subject to a greater energetic penalty
upon dehydration (L.Z. and S.A.S., unpublished data).
How does R632 help generate the high efficacy with
which cNMPs enhance channel activation? Our finding
that efficacy is relatively unchanged after individual muta-
tions of 10 CNBD residues that are near neighbors of R632
strongly argues that the R632A mutation selectively dis-
rupts strong, local interactions between R632 and ligand.
This view is consistent with our computational results that
R632 makes some of the strongest electrostatic and VDW
contacts with ligand of any CNBD residue. According to
a six-state allosteric gating model, the R632Amutation re-
sults in a 1700-fold loss of ligand binding affinity to the
open state of the channel, as opposed to only a 30-fold
loss of binding affinity to the closed state. This state-
dependent interaction implies that R632 must move
relative to the bound cNMP during channel gating.
Studies of various proteins have suggested that move-
ments of the C helix, in which R632 is located, contribute
to state-dependent interactions of ligand with the CNBD.
Thus, in the regulatory subunit of PKA, the C helix is
thought to swing 90 away from the binding pocket upon
ligand dissociation (Gullingsrud et al., 2006; Vigil et al.,
2006). In MlotiK1, the C helix in the unliganded R438A
CNBD (equivalent to R632A) moves 4.4 A˚ away from the
binding pocket compared to its location in the cAMP-
bound wild-type CNBD (Clayton et al., 2004). Although
our 40 ns MD simulations are too brief to provide insight
into large-scale conformational changes in HCN2, we55–670, June 2007 ª2007 Elsevier Ltd All rights reserved 667
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cNMP from the wild-type CNBD destabilize the position of
the C helix relative to the core of the CNBD. In contrast to
the mobility of the C helix, our finding that b roll residues
make limited contributions toward efficacy suggests that
this region remains stationary relative to ligand during gat-
ing, in agreement with previous results (Tibbs et al., 1998).
How is ligand-dependent movement of the C helix cou-
pled to enhanced channel opening? Application of PCA to
the MD trajectories reveals a series of coupled intrasubu-
nit movements extending from the B and C helices of the
CNBD to the C0–F0 helices of the C linker. These move-
ments lead to an intersubunit rotational-translational
movement of the A0 and B0 helices of the C linker in an ad-
jacent subunit. Importantly, because the N terminus of the
A0 helix is directly attached to the S6 transmembrane seg-
ment, which forms the gate of the channel (Rothberg et al.,
2002), this motion may enhance channel opening by di-
rectly applying force to the gate. A rotational movement of
the A0 helix has also been suggested to underlie the gating
of CNG channels based on state-dependent changes in
the pattern of cysteine reactivity with sulfhydryl-modifying
reagents (Johnson and Zagotta, 2001). Long-range con-
formational changes in the quaternary structure of HCN2
have also been reported in an MD study that employed
principal component and Elastic Network Model analyses
(Berrera et al., 2006).
Presently, MD simulations are still limited in the sam-
pling of protein conformational space and utilize imperfect
potential energy functions in various force fields. The for-
mer factor likely accounts for our failure to observe large-
scale structural alterations with point mutations that have
dramatic phenotypes, such as R591E and R632A, as well
as with simulations of the unliganded CNBD. Longer sim-
ulation times, implicit treatment of solvent, and algorithms
that enhance conformation sampling might reveal larger
conformational changes underlying ligand gating. None-
theless, our present results reveal the power of combining
MD simulations and functional mutagenesis to provide
new insights into channel structure and ligand gating.
EXPERIMENTAL PROCEDURES
Molecular Biology
Point mutations were introduced by a two-step PCRmethod, followed
by restriction enzyme digestion. DNA fragments were inserted into the
vector through BglII andMscI sites. Positive plasmid DNAwas retrans-
formed into a Stable2 cell line, and purified DNAwas linearized by SphI
to make a template for in vitro RNA transcription. mRNA was synthe-
sized by using the mMessage mMachine Kit (Ambion, #1340).
Electrophysiology
Xenopus oocytes were injected with 25–50 ng cRNA, and current re-
cordings from inside-out patches were obtained after 3–7 days with
1–3 MU patch pipettes and an EPC-9 amplifier (Heka) (Goulding
et al., 1992). Identical bath and pipette solutions contained (in mM):
107 KCl, 5 NaCl, 10 HEPES, 1 MgCl2, and 1 EGTA (pH 7.4). Currents
were elicited by a series of 3 s hyperpolarizing steps to voltages rang-
ing from 90 mV (or 80 mV with the cNMP) to170 mV (or 160 mV
with the cNMP) in 10 mV increments.
Tail current activation curves were determined by plotting peak tail
current amplitude (Itail) measured at 40 mV after hyperpolarizing668 Structure 15, 655–670, June 2007 ª2007 Elsevier Ltd All righsteps to different voltages. Itail was normalized by the maximal tail
current amplitude after extreme negative voltage steps where voltage-
dependent activation is complete (IN). Tail current activation curves
were fitted by a Boltzmann function to obtain the mid-point voltage
of activation (V1/2) and slope factor s, in mV (Wainger et al., 2001).
The effect of the cNMP to shift voltage gating to more positive poten-
tials was measured by the difference between V1/2 values in the pres-
ence and absence of cAMP (DV1/2). We alsomeasured the effect of the
cNMP to increase IN from the ratio IN[cNMP]/IN[0], where IN[cNMP]
and IN[0] are the maximal tail current amplitudes in the presence
of a given concentration of cNMP and in the absence of the cNMP, re-
spectively. Dose-response curves were constructed by plotting DV1/2
and IN[cNMP]/IN[0] as a function of cNMP concentration. Fits of the
Hill equation to DV1/2 dose-response curves provided values for the
maximal voltage shift at saturating cNMP concentrations (DVmax) and
the concentration producing a half-maximal shift, K1/2(V). Fits of the
Hill equation to IN[cNMP]/IN[0] dose-response curves yielded values
for the maximal relative current increase at saturating ligand concen-
trations, IN[sat]/IN[0], and the concentration producing a half-maximal
increase in current, K1/2(I).
Cyclic Allosteric Model and Calculation of Dissociation
Constants for cNMP Binding
HCNchannel gating and itsmodulation by the cNMPwas described by
a six-state cyclic allosteric model to derive values of KO and KC, the
dissociation constants for binding to the open and closed states of
the channel, respectively (Figure S4). The dissociation constants
were determined from four experimentally determined parameters:
(1) IN[sat]/IN[0]; (2) DVmax; (3) s (the Boltzmann slope factor, in mV);
(4) K1/2(V). As derived in Supplemental Experimental Procedures, KO














(see Equation 17A in Supplemental Data).
KO can also be obtained from K1/2(I) and IN[sat]/IN[0]:
KO =K1=2ðIÞ IN½0
IN½sat
(see Equation 18A in Supplemental Data).
The independent estimates of KO and KC calculated from K1/2(V) (by
using Equations 16A and 17A in Supplemental Data) or K1/2(I) (by using
Equations 13A and 18A in Supplemental Data) are in good agreement
(Figure S4B), yielding quantitative support for the model.
Set-Up of Molecular Dynamics Simulation
Tetrameric structures of the ligand-bound C-terminal region of HCN2
were assembled according to crystallographic symmetry defined in
the original PDB file (1Q5O for cAMP or 1Q3E for cGMP). A total of
45 combined residues related to the current study were missing or
not fully resolved in the two structures (see PDB files for a complete
list). Missing residues and side chains were rebuilt with Swiss PDB
Viewer, which was also used to introduce point mutations. The side
chain conformations were then optimized with SCWRL3.0 (Canutescu
et al., 2003). The complete list of fully or partially unresolved residues is
provided in the above-mentioned PDB files. Below, we list those par-
tially or fully unresolved residues that either directly contact ligand
(based on partially resolved positions) or are the nearest neighbors
to residues that directly contact ligand. For the cAMP-bound structure:
I550, K552, K553, and K638 are the nearest neighbors of residues that
directly contact cAMP. For the cGMP-bound structure: R635 and I636
are in direct contact with ligand; K552, K553, K567, K570, E571, G637,ts reserved
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Cyclic Nucleotide Gating of HCN ChannelsK638, and K639 are the nearest neighbors of residues that directly
contact cGMP.
MD simulations were carried out with the GROMACS3.2.1 package
(Lindahl et al., 2001) by using the GROMOS96 43a1 force field. The
protonation states of charged residues were determined with help
from Dr. Jiang Zhu, by using pKa values calculated by MCCE
(Georgescu et al., 2002) based on DELPHI (Honig and Nicholls,
1995; Rocchia et al., 2002). DELPHI was also used in calculating the
electrostatic potential shown in Figures 1 and 4. The topology param-
eters for cNMPs were generated by using the ProDrg Server (Schuttel-
kopf and van Aalten, 2004), based on the coordinates from the crystal
structures. The partial charges of cAMP and cGMPwere adapted from
the RNA bases, ADE and GUA, respectively, in the same force field.
The simple point charge (SPC) water model was used to simulate
the solvent explicitly (Berendsen et al., 1981). The protein was placed
in the center of a cubic box with an explicit solvent shell extending 10 A˚
to the walls of the box; Cl was added to neutralize the system. The
simulation was performed at a constant temperature (300 K) and
pressure (1 bar) by using the Berendsen coupling approach, with
tT = 0.1 ps and tP = 0.5 ps, respectively. Lennard-Jones (VDW) interac-
tions were evaluated with the twin-range method with cutoff distances
set at 9 A˚ and 14 A˚. Electrostatic interactions were calculated with the
particle mesh Ewald (PME) method with a 9 A˚ cutoff. Covalent bond
lengths were constrained by using the LINCS algorithm. A time step
of 2 fs was used.
Separate energy minimizations were performed before and after
addition of Cl to neutralize the system and relax the solvent environ-
ment; all heavy atoms of protein and cNMP were fixed. A short MD
simulation of 500 ps was then performed with positional restraints on
protein and bound ligand, followed by standard MD simulations. Stan-
dard GROMACS programs were used in analyzing theMD trajectories.
For H bond analysis, the cutoff angle was set at 30, and the cutoff
radius was set at 3.5 A˚. Visual Molecular Dynamics (VMD) was used
to produce most of the structure-related figures (Humphrey et al.,
1996).
Binding Energy Analysis
The energy analysis program in GROMACS (g_energy) was used to
calculate the short-term/long-term VDW energy and short-range
Coulomb energy. Long-range Coulomb (PME) energy was calculated
by using a modified a script in GROMACS (pmetest.c in 3.3) to explic-
itly extract long-range electrostatic energy for each energy group. A di-
electric constant of 1 was used to calculate the electrostatic (Coulomb)
potential energy in Figure 2 to maintain consistency with the imple-
mentation in the force fields used during the MD simulations. Although
this simplifies the influence of the local dielectric environment, such
energies are solely used to provide a qualitative means for identifying
residues likely to make strong electrostatic contacts (Dittrich and
Schulten, 2006) with ligand, which we then experimentally test by
using mutagenesis.
Principal Component Analysis
Principal component analysis (PCA) was used to dissect the most sig-
nificant protein motions associated with ligand binding. Protein coor-
dinates were extracted from each time frame of 40 ns MD trajectories
for the unliganded and cAMP-bound protein and concatenated. Global
translational and rotational movements during the trajectories were
removed by using a least-squares fitting routine. The covariance ma-
trix of C-a atoms was calculated and diagonalized by using g_covar
from GROMACS to yield the eigenvalues and eigenvectors. To check
the conformation space covered by each eigenvector, we projected
the MD trajectory onto the first eight eigenvectors (using g_anaeig)
and crossplotted the results in a pairwise manner (Figure 8B;
Figure S5). Lastly, we calculated two extreme projections along the
first eigenvector from the combined MD trajectory. Based on the pro-
tein structures of these two extreme projections, a porcupine plot was
generated to illustrate the direction and amplitude of conformational
changes represented by the first eigenvector.Structure 15, 6Supplemental Data
Supplemental Data include a section with a derivation of the equations
used to calculate ligand-binding dissociation constants from the
experimental data according to the cyclic allosteric model. In addition,
there are five figures, one table, and twomovies. These items are avail-
able at http://www.structure.org/cgi/content/full/15/6/655/DC1/.
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